1-s2.0-S2049080121003617-main.pdf (375.98 kB)
Download fileThe travails of therapeutic modifications in cancer care amidst the COVID-19 pandemic: future directions and lessons learned
journal contribution
posted on 2022-02-04, 17:08 authored by Talal Almas, Muhammad Hassan Naeem Goraya, Zahid Ijaz Tarar, Tarek Khedro, Maryam Ehtesham, Uzair Malik, Abdulla Hussain Al-Awaid, Muhammad Ali Niaz, Lamees Alshaikh, Ali RifaiThe coronavirus disease 2019 (COVID-19) pandemic continues to
pose challenges of unparalleled magnitude. Unsurprisingly, COVID-19
amongst cancer patients has been associated with higher mortality
rates and ventilation support, with the highest mortality associated with
hematological malignancies [1–3]. The burgeoning risk of disease progression secondary to delayed treatment-seeking behavior precipitated
by fears surrounding the pandemic has resulted in significant morbidity
and mortality. While the risk stratification and categorization of cancer
care priority remains elusive, we hereby provide some suggestions to
bridge the chasm that exists in our current cancer care regimens despite
recent suggestions pertaining to therapeutic modifications.
History
Comments
The original article is available at https://www.sciencedirect.com/Published Citation
Almas T, et al. The travails of therapeutic modifications in cancer care amidst the COVID-19 pandemic: future directions and lessons learned. Ann Med Surg (Lond). 2021;66:102411.Publication Date
29 May 2021External DOI
PubMed ID
34094529Department/Unit
- Undergraduate Research
Publisher
Elsevier B.V.Version
- Published Version (Version of Record)